188 related articles for article (PubMed ID: 22212647)
1. Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.
Aguiar C; Batista AM; Pavan TB; Almeida EA; Guariento ME; Wanderley JS; Costa SC
Trop Med Int Health; 2012 Mar; 17(3):368-73. PubMed ID: 22212647
[TBL] [Abstract][Full Text] [Related]
2. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
4. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
[TBL] [Abstract][Full Text] [Related]
5. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
[TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in Chagas disease after specific treatment.
Britto C; Cardoso A; Silveira C; Macedo V; Fernandes O
Medicina (B Aires); 1999; 59 Suppl 2():176-8. PubMed ID: 10668261
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.
Fabbro D; Velazquez E; Bizai ML; Denner S; Olivera V; Arias E; Pravia C; Ruiz AM
Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740013
[TBL] [Abstract][Full Text] [Related]
8. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
[TBL] [Abstract][Full Text] [Related]
9. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
Basombrío MA; Segura MA; Nasser JR
J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
[TBL] [Abstract][Full Text] [Related]
10. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
[TBL] [Abstract][Full Text] [Related]
11. New advances in the management of a long-neglected disease.
Urbina JA
Clin Infect Dis; 2009 Dec; 49(11):1685-7. PubMed ID: 19877968
[No Abstract] [Full Text] [Related]
12. Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up.
Fernandes CD; Tiecher FM; Balbinot MM; Liarte DB; Scholl D; Steindel M; Romanha A
Mem Inst Oswaldo Cruz; 2009 Feb; 104(1):27-32. PubMed ID: 19274372
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.
Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M
J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal follow up of serological response in children treated for Chagas disease.
Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
[TBL] [Abstract][Full Text] [Related]
16. Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study.
Jurado Medina L; Chassaing E; Ballering G; Gonzalez N; Marqué L; Liehl P; Pottel H; de Boer J; Chatelain E; Zrein M; Altcheh J
Lancet Infect Dis; 2021 Aug; 21(8):1141-1150. PubMed ID: 33836157
[TBL] [Abstract][Full Text] [Related]
17. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
[TBL] [Abstract][Full Text] [Related]
18. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
[TBL] [Abstract][Full Text] [Related]
19. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors].
Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C
Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836
[TBL] [Abstract][Full Text] [Related]
20. Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study.
Andrade MC; Oliveira Mde F; Nagao-Dias AT; Coêlho IC; Cândido Dda S; Freitas EC; Coelho HL; Bezerra FS
Rev Soc Bras Med Trop; 2013; 46(6):776-8. PubMed ID: 24474023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
